Bryn Mawr Trust CO Harmony Biosciences Holdings, Inc. Transaction History
Bryn Mawr Trust CO
- $5.48 Billion
- Q3 2024
A detailed history of Bryn Mawr Trust CO transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 146 shares of HRMY stock, worth $4,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146Holding current value
$4,714% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$362 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$112 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$84.2 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$62.3 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.91B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...